BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 8, 2025
Home » Authors » Jim Shrine

Articles by Jim Shrine

Sangart Raises $50M In Series F For Blood Substitute Programs

April 5, 2007
By Jim Shrine

Sangart Raises $50M In Series F For Blood Substitute Programs

April 5, 2007
By Jim Shrine

Surface Logix Meets Milestones, Adds $20M To Series D Round

April 4, 2007
By Jim Shrine

Surface Logix Meets Milestones, Adds $20M To Series D Round

April 4, 2007
By Jim Shrine

Radius Attracts Series C Funds For Programs In Women's Health

April 3, 2007
By Jim Shrine
Radius brought in $29 million from a potential $57.5 million Series C financing round, money that will be used to advance development of four programs targeting women's health. (BioWorld Today)
Read More

Radius Attracts Series C Funds For Programs In Women's Health

April 3, 2007
By Jim Shrine
Radius brought in $29 million from a potential $57.5 million Series C financing round, money that will be used to advance development of four programs targeting women's health. (BioWorld Today)
Read More

Anesiva Starts Phase III Trial To Evaluate Pain Product Zingo

March 29, 2007
By Jim Shrine

Anesiva Starts Phase III Trial To Evaluate Pain Product Zingo

March 29, 2007
By Jim Shrine

Frost Leads Three-Way Merger That Includes Acuity, Froptix

March 28, 2007
By Jim Shrine

Frost Leads Three-Way Merger That Includes Acuity, Froptix

March 28, 2007
By Jim Shrine
Previous 1 2 … 14 15 16 17 18 19 20 21 22 … 25 26 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 5, 2025.
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing